1. Home
  2. JAZZ vs DUOL Comparison

JAZZ vs DUOL Comparison

Compare JAZZ & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

N/A

Current Price

$162.98

Market Cap

10.4B

Sector

Health Care

ML Signal

N/A

Logo Duolingo Inc.

DUOL

Duolingo Inc.

N/A

Current Price

$117.30

Market Cap

8.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
JAZZ
DUOL
Founded
2003
2011
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
8.4B
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
JAZZ
DUOL
Price
$162.98
$117.30
Analyst Decision
Strong Buy
Buy
Analyst Count
16
17
Target Price
$207.19
$270.00
AVG Volume (30 Days)
1.0M
2.6M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
338.81
EPS
N/A
8.04
Revenue
$4,157,832,999.00
$964,271,000.00
Revenue This Year
$6.05
$40.64
Revenue Next Year
$6.23
$22.43
P/E Ratio
N/A
$14.23
Revenue Growth
4.14
39.86
52 Week Low
$95.49
$112.41
52 Week High
$182.99
$544.93

Technical Indicators

Market Signals
Indicator
JAZZ
DUOL
Relative Strength Index (RSI) 48.53 20.55
Support Level $162.24 $112.41
Resistance Level $168.47 $125.00
Average True Range (ATR) 4.02 7.39
MACD -0.39 -2.31
Stochastic Oscillator 36.31 8.02

Price Performance

Historical Comparison
JAZZ
DUOL

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.

Share on Social Networks: